Back to search
FDAFDA · Food and drugs·Recall number D-0375-2022

Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

Published January 19, 2022 · Recall initiated: December 15, 2021

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
CLOBETASOL PROPIONATE
Manufacturer
Taro Pharmaceuticals U.S.A., Inc.
Distributor
Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
UPC
0351672129422
Lot
Lot# AC13786, exp. date DEC 2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card